"/> Tocris Bioscience™ dTAG-7 | B-LABO France

Tocris Bioscience™ dTAG-7

Réf. : BL-RE-125636Réf. fabricant : 18798966 5 mg
530,22 € HT

First generation Degrader for mutant FKBP12F36V fusion proteins; useful alternative to genetic methods for target validation

Nom chimique ou matériau
(1 R)-3-(3,4-Dimethoxyphenyl)-1-(2-((19-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2,18-dioxo-7,10,13-trioxa-3,17-diazanonadecyl)oxy)phenyl)propyl (2 S)-1-(-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate
CAS
2064175-32-0
Quantité
5 mg
Cible
TAG Degradation Platforms
Formule moléculaire
C63H79N5O19
Marque
Tocris Bioscience

dTAG-7 is a first generation Degrader for mutant FKBP12F36V fusion proteins. Comprises a ligand selective for F36V single-point mutated FKBP12, a linker and a cereblon-binding ligand. Application of dTAG-7 induces rapid, reversible and selective degradation of FKBP12F36V fusion proteins

in vitro

and

in vivo

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-125636
Réf. fabricant18798966
Nom chimique ou matériau(1 R)-3-(3,4-Dimethoxyphenyl)-1-(2-((19-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2,18-dioxo-7,10,13-trioxa-3,17-diazanonadecyl)oxy)phenyl)propyl (2 S)-1-(-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate
CAS2064175-32-0
Quantité5 mg
CibleTAG Degradation Platforms
Formule moléculaireC<sub>63</sub>H<sub>79</sub>N<sub>5</sub>O<sub>19</sub>
Pureté98%
Une question, une configuration particulière ?
Contactez-nous pour un devis.